VASH2 and breast carcinoma: When comparing the abundance of deTyr-Tub across commonly utilized breast cancer cell lines, the level of the TCP components, VASH1, VASH2, and SVBP, did not show a clear correlation with the amount of deTyr-Tub (Figure 5B).